Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
Saliva sample in a test tube on a laboratory countertop

Jun 3, 2026

Hidden AI Revolution Reshapes Global Healthcare Diagnostics Market

The article discusses the significant yet often overlooked advancements in artificial intelligence (AI) within the healthcare diagnostics sector, particularly emphasizing the importance of upstream algorithmic discovery over consumer-facing applications.Venture capital investments in medical AI are primarily directed towards consumer software, neglecting the upstream processes that drive true innovation in diagnostics. This misallocation risks overlooking critical advancements in biomarker disco
A minimalist illustration of a stethoscope and heart symbolizing healthcare.

Jun 3, 2026

Microsoft & Mayo Clinic Team Up to Build Frontier AI Model for Healthcare

Microsoft and Mayo Clinic have announced a strategic partnership aimed at developing a cutting-edge AI model tailored specifically for the healthcare sector.This innovative collaboration seeks to leverage Mayo Clinic's extensive clinical expertise alongside Microsoft’s advanced AI capabilities and de-identified patient data. The goal is to enhance diagnostic accuracy, optimize treatment decisions, and ultimately improve patient outcomes. Dr. Gianrico Farrugia, CEO of Mayo Clinic, emphasized that
A minimalist representation of a quantum chip and Majorana particle

Jun 3, 2026

Top News Today: Microsoft Quantum Push, Biotech Funding, MBA Careers, AI Coding & Crypto Rout

Recent advancements in quantum computing, biotech funding, and AI coding are shaping the landscape of technology and life sciences.Microsoft has set an ambitious target to launch commercially viable quantum computing technology by 2029. This initiative will leverage its latest Majorana-based quantum chip alongside artificial intelligence, aiming to enhance various fields including healthcare and materials science. The integration of AI with quantum computing is anticipated to unlock new avenues
A test tube with a liquid sample on a lab countertop

Jun 3, 2026

Exclusive: Apoha, startup pioneering AI based on liquid 'wave form' data, debuts with $36 million

Apoha, a pioneering startup in AI-driven material science, has emerged from stealth with $36 million in funding to develop innovative substances based on unique liquid wave form data.The funding comprises a seed round from 2024 and a recent unlettered round, led by Singular, with support from other venture firms and a grant from Innovate UK. Apoha aims to leverage a novel type of data—wave forms generated by materials in liquid under external forces—to enhance the creation and modification of va
A minimalist representation of a clipboard with an AI brain icon, symbolizing AI oversight in healthcare.

Jun 3, 2026

NHS AI scribe rollout should include national oversight, report finds

A recent report emphasizes the necessity of national oversight in the deployment of AI scribes within the NHS to ensure their safe and effective use.The report, stemming from a public dialogue commissioned by the healthcare AI firm Newton’s Tree, highlights that national bodies must oversee the implementation of AI scribes. This oversight is crucial for ensuring data security, staff training, and the accuracy of AI-generated documentation. Conducted in March 2026, the dialogue revealed a low lev
A regulatory document in a biotech lab

Jun 3, 2026

AI Has Arrived In Biotech CMC Amid Patchwork Governance

AI integration in biotech's regulatory affairs and CMC is advancing rapidly, but governance frameworks are struggling to keep pace.Artificial intelligence (AI) is increasingly being adopted in regulatory affairs and Chemistry, Manufacturing, and Controls (CMC) within biotech companies. Many organizations are utilizing AI for tasks such as drafting documents, summarizing data, and developing responses to health authorities. However, this adoption often occurs without fully established governance
A minimalist illustration of a key and lock representing cybersecurity access.

Jun 3, 2026

Anthropic Offers EU ENISA Access to Mythos After San Francisco Talks

Anthropic has extended an invitation to the European Union's cyber agency, ENISA, to access its cybersecurity AI, Mythos, through Project Glasswing, following discussions in San Francisco. This development comes after a period of restricted access, as EU officials sought similar visibility on vulnerabilities that U.S. partners had already gained.Mythos, which is designed to autonomously identify and exploit software vulnerabilities, is not a public tool but part of a controlled-access program ai
A patient's hand holding a health history document in a softly lit room.

Jun 3, 2026

Novellia Secures $18M Series A to Scale Patient-Powered Data Platform, Solving Pharma's $50B Problem

Novellia has successfully raised $18 million in Series A funding to enhance its innovative patient-powered data platform, addressing a significant gap in pharmaceutical research.The funding round, led by Spark Capital and supported by several prominent investors, brings Novellia's total funding to $28 million. This investment comes as the company launches a new mobile app aimed at empowering patients by providing secure access to their complete health history. Novellia's approach focuses on util
A pill bottle on an office desk with a city view

Jun 3, 2026

GSK switches CEO as Trump tariffs test pharma

GSK is undergoing a significant leadership change as CEO Emma Walmsley steps down, with Luke Miels set to take over in January amidst challenges posed by new US tariffs on pharmaceuticals.In a surprising move, GSK announced that chief commercial officer Luke Miels will succeed Emma Walmsley as CEO on January 1. Walmsley, who has led the company for nearly nine years, emphasized that 2026 is critical for GSK's future direction, suggesting that new leadership is timely as the company faces externa
A broken pill bottle with scattered pills on a dark background.

Jun 3, 2026

Purdue Pharma to be dissolved as US judge says to approve bankruptcy

Purdue Pharma, the maker of OxyContin, is set to be dissolved following a US bankruptcy judge's approval of a settlement addressing numerous lawsuits linked to the opioid crisis. This decision marks a significant step in resolving the company's controversial history of aggressive marketing and its role in the addiction epidemic.The bankruptcy plan, which is expected to be finalized in an upcoming court hearing, will result in the cessation of Purdue Pharma's operations. The company has been unde
Flat illustration of a computer chip representing data analytics in drug development.

Jun 3, 2026

Evotec Appoints Rui Wang as Head of Global In Silico and AI

Evotec has appointed Rui Wang as the new Executive Vice President, Head of Global In Silico and AI, marking a significant step in enhancing its AI-driven research and development capabilities.With over two decades of experience in the pharmaceutical and biotechnology sectors, Wang will lead efforts to integrate data analytics and AI throughout Evotec's R&D processes. His previous role at AstraZeneca involved overseeing data and AI initiatives, equipping him with the expertise to drive innovation
A medicine bottle on a pharmacy shelf in low light

Jun 3, 2026

Marksans Pharma Expands European Reach with Acquisition of Netherlands-Based QliniQ B.V.

Marksans Pharma has made a significant move to strengthen its presence in Europe by acquiring QliniQ B.V., a Dutch pharmaceutical firm, for EUR 7.5 million.This acquisition marks Marksans' entry into the Dutch healthcare market, enhancing its distribution and market access capabilities across regulated European regions. The deal is seen as a crucial step in facilitating the commercialization of both existing and future products within the European Union.Mark Saldanha, the Chairman and Managing D